期刊文献+

通心络对溶血磷脂酰胆碱所致人脐静脉内皮细胞损伤的影响

The effects of Tong Xin-Luo on human umbilical vein endothelial cells impaired by lysophosphatidylcholine
原文传递
导出
摘要 目的观察通心络(TXL)对溶血磷脂酰胆碱(LPC)致人脐静脉内皮细胞损伤作用的影响。方法制备通心络含药血清,人脐静脉内皮细胞培养,分为(1)正常对照组;(2)LPC损伤组;(3)通心络血清组;(4)通心络+LPC干预组。观察细胞形态变化,MTr法检测各组细胞OD值。结果与对照组(0.380±0.023)相比,溶血磷脂酰胆碱(0.320±0.024)明显降低细胞活性,促进细胞死亡(P〈0.05);通心络干预后(0.424±0.034),细胞活性明显增加,细胞死亡减少(P〈0.05)。结论通心络对溶血磷脂酰胆碱致人脐静脉内皮细胞损伤具有保护作用。 Objective To investigate the effects of Tong Xin-Luo on cultured human umbilical vein endothelial cells (HUVECs) impaired by Lysophosphatidylcholine. Methods The herbage-contained serum of TXL was prepared, HUVECs were cultured in vitro. The study was designated to 4 group : normal control, LPC group, TXL group, and TXL + LPC intervened group. The cell function was determined by cell morphology and MTF colorimetric assay. Results Compaired with normal control group ( 0. 380 ± 0. 023 ), LPC (0. 320 ± 0. 024 ) could significantly decrease the cells activity, promote cells death ( P 〈 0.05 ). After TXL intervened(0. 424 ± 0. 034) , cells activity was significantly increased, cells death was d significantly decreased( P 〈0. 05 ). Conclusions Tong Xin-Luo could protect human umbilical vein endo- thelial cells function by against the LPC-induced damage.
出处 《中国医师杂志》 CAS 2012年第5期607-609,共3页 Journal of Chinese Physician
关键词 心血管药物/治疗应用 胶囊△ 溶血磷脂酰胆碱类/副作用 血管疾病/化学诱导/ 治疗 脐静脉/病理学 内皮 血管/病理学 Cardiovascular agents/therapeutic use Capsules A Lysophosphatidylcholines/adverse effects Vascular diseases/chemically induced/therapy 'Umbilical veins/pathology Endothelium, vascular/pathology
  • 相关文献

参考文献5

  • 1Arrebola-Moreno AL, Laclaustra M, Kaski JC. Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol,2012,65( 1 ) :80-90.
  • 2Koenig W, Karakas M, Zierer A, et al. Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. Clin Chem ,2011,57 ( 8 ) : 1196-1200.
  • 3Zeibig S, Li Z, Wagner S, et al. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. C irc Res, 2011,108 ( 6 ) :695-703.
  • 4Schmitz G, Ruebsaamen K. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis, 2010,208 (1) :10-18.
  • 5Liang GH, Park S, Kim MY, et al. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage. Life Sci, 2010,86 (19-20) :733-739.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部